A kind of C-3 fully substituted oxindole derivative and its synthesis method and application
A technology of indole derivatives and synthesis methods, which is applied in the field of synthetic medicine and chemical industry, and can solve the problems that are not conducive to the application of C-3 fully substituted oxindole derivatives and their industrial synthesis and industrialization. The post-processing is cumbersome and other problems, and the effect of low cost, few reaction steps and short reaction route is achieved
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0093]
[0094] Dissolve MBH carbonate (0.2mmol), β-ICD (0.25mmol) and allylpalladium chloride (0.05mmol) in 1mL i-PrOAc:DCM=1:1 mixed solvent, and prepare mixed solution A, in Stir at room temperature for 10 minutes. Then N-alkyl-N-aryl diazoamide (0.3 mmol) was dissolved in 1 mL i-PrOAc:DCM = 1:1 mixed solvent to prepare solution B. solution B at 20 o C, add mixed solution A with a syringe pump within 1 hour. Stir for 36 to 48 hours, and the reaction mixture is purified by column chromatography to obtain a pure product whose structure is shown in formula (a), which is tert-butyl-2-((R)-(4-bromophenyl)-( R)-1,3-dimethyl-2-oxindole-3-substituted)meth)acrylate, the yield is 64%, the dr value is equal to 95:5, and the ee value is greater than 99%. Compound shown in formula (a) 1 H NMR schematic as figure 1 As shown, its 13 C NMR schematic as figure 2 As shown, the liquid phase diagram of the racemic product is shown in image 3 As shown, the liquid phase diagram of i...
Embodiment 2
[0097]
[0098]Dissolve MBH carbonate (0.2mmol), β-ICD (0.25mmol) and allylpalladium chloride (0.05mmol) in 1mL i-PrOAc:DCM=1:1 mixed solvent, and prepare mixed solution A, in Stir at room temperature for 10 minutes. Then N-alkyl-N-aryl diazoamide (0.3 mmol) was dissolved in 1 mL i-PrOAc:DCM = 1:1 mixed solvent to prepare solution B. Add solution B to mixed solution A with a syringe pump within 1 hour at 20°C. Stir for 36 to 48 hours, and the reaction mixture is purified by column chromatography to obtain a pure product whose structure is shown in formula (b), which is methyl-2-((R)-((R)-5-bromo-1 , 3-Dimethyl-2-oxindole-3-substituted) (phenyl) meth)acrylate, the yield was 75%, the dr value was equal to 91:9, and the ee value was race. Compound shown in formula (b) 1 H NMR schematic as Figure 5 As shown, its 13 C NMR schematic as Image 6 shown.
[0099] 1 H NMR (400MHz, CDCl 3 )δ7.31(m,6H),6.90(s,1H),6.30(s,1H),5.54(s,1H),4.63(s,1H),3.64(s,3H),3.09(s,3H ),1.38(s...
Embodiment 3
[0101]
[0102] Dissolve MBH carbonate (0.2mmol), β-ICD (0.25mmol) and allylpalladium chloride (0.05mmol) in 1mL i-PrOAc:DCM=1:1 mixed solvent, and prepare mixed solution A, in Stir at room temperature for 10 minutes. Then N-alkyl N-aryl diazoamide (0.3 mmol) was dissolved in 1 mL of i-PrOAc:DCM = 1:1 mixed solvent to prepare solution B. Add solution B to mixed solution A with a syringe pump within 1 hour at 20°C. Stirring for 36-48 hours, the reaction mixture was purified by column chromatography to obtain a pure product, the structure of which was shown in formula (c), which was tert-butyl-2-((R)-((R)-1,3- Dimethyl-2-oxindole-3-substituted)(phenyl)meth)acrylates with a yield of 64%, a dr value greater than 95:5, and an ee value equal to 84%. Compound shown in formula (c) 1 H NMR schematic as Figure 7 As shown, its 13 C NMR schematic as Figure 8 As shown, the liquid phase diagram of the racemic product is shown in Figure 9 As shown, the liquid phase diagram of it...
PUM
| Property | Measurement | Unit |
|---|---|---|
| control rate | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



